Literature DB >> 10632961

Phospholipase C activation by prostacyclin receptor agonist in cerebral microvascular smooth muscle cells.

P A Parkinson1, H Parfenova, C W Leffler.   

Abstract

The mechanism through which iloprost permits cerebral vasodilation induced by specific stimuli is incompletely understood. Previous study suggests there might be interplay between the adenylyl cyclase and phospholipase C (PLC) systems. Coupling of the prostacyclin receptor with the PLC pathway system was investigated. Iloprost, a stable prostacyclin analog, was used as a prostacyclin receptor agonist. We investigated the effects of iloprost (10-12-10-6 M) on inositol 1,4,5-trisphosphate (IP3) production by piglet cerebrovascular smooth muscle cells in primary culture. Iloprost caused concentration- and time-dependent increases in IP3 production in control cells and in cells pretreated with LiCl (to prevent further IP3 metabolism). Iloprost treatment (10-12 M) of cerebrovascular smooth muscle cells, in the absence and presence of 20 mM LiCl, resulted in 2-fold and 4-fold increases in the formation of IP3, respectively. In contrast, 10-10 M to 10-6 M iloprost, either in the presence or absence of LiCl, induced moderate or no increase in IP3 formation. Iloprost (10-10-10-12 M) strongly stimulated diacylglycerol (DAG) generation, whereas higher concentrations (10-8 M) did not induce an increase. In conclusion, the results suggest that prostacyclin receptors on cerebromicrovascular smooth muscle can couple to PLC, generating the second messengers, IP3 and DAG.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632961     DOI: 10.1046/j.1525-1373.2000.22307.x

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  4 in total

1.  Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release.

Authors:  Elizabeth L Cureton; Aaron Strumwasser; Rita O Kwan; Kristopher C Dozier; Brian Curran; Javid Sadjadi; Gregory P Victorino
Journal:  J Appl Physiol (1985)       Date:  2010-12-23

2.  Modeling hypertrophic IP3 transients in the cardiac myocyte.

Authors:  Michael Cooling; Peter Hunter; Edmund J Crampin
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

Review 3.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

4.  Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.

Authors:  K B Chow; Y H Wong; H Wise
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.